2026 NPPES data Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist NPI 1033897814 PHARMD
Verify on CMS →

ANNA PEYTON NAVARRETE, PHARMD

Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist in PALM SPRINGS, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
245
Medicare Part D claims · 106 beneficiaries · Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist avg: 256
Generic prescribing
59%
generic claims · 41% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

ANNA PEYTON NAVARRETE, PHARMD filed 245 Medicare Part D claims in 2023 as a Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist in PALM SPRINGS, California, prescribing 59% generic.

245
Part D claims, 2023
59%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

ANNA PEYTON NAVARRETE, PHARMD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

245 49th percentile higher than 49% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). This entry sits in this band. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

What does the federal data show about ANNA PEYTON NAVARRETE, PHARMD?

Quality data not reported

NPI registry status

Active

Issued 07/10/2023

NPI 1033897814

Primary specialty

Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist

Mid-sized

12,377 US NPIs in this specialty

Medicare Part D claims

245 4% vs specialty avg

2023 prescription claims

Specialty avg: 256

Specialty distribution in California

How Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist compares to other specialties among California providers

California providers

Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist share within California

1. Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist share within California

Specialty board-certification context

Estimated specialty board-certified rate — Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist ABMS/AOA estimate

Est. board-certified rate (Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ANNA PEYTON NAVARRETE, PHARMD appears in the CMS NPPES registry as a Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist provider holding PHARMD credentials at 275 N EL CIELO RD, PALM SPRINGS, CA, 92262, with a listed phone of (760) 320-8814. NPI 1033897814 was issued on 07/10/2023. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what PEYTON NAVARRETE most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 245 prescription claims written by this provider, covering 106 Medicare beneficiaries and totaling roughly $78K in drug spend, split 41% brand-name and 59% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist is a mid-sized specialty nationwide, with 12,377 enrolled providers across 55 states and an average of 256 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

275 N EL CIELO RD
PALM SPRINGS, CA 92262

Provider Details

NPI 1033897814
Specialty Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist
Credentials PHARMD
Gender Female
NPI Issued 07/10/2023

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to ANNA PEYTON NAVARRETE, PHARMD. To verify ANNA PEYTON NAVARRETE, PHARMD's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

ANNA PEYTON NAVARRETE, PHARMD — brand share 41.0%
Specialty average (est.)

41% brand-name claims vs 59% generic, on 245 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

245
Total Claims
$78K
Total Drug Cost
106
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
446
Total Day Supply
13,182
Brand vs Generic
41% brand / 59% generic
Brand Drug Cost
$75K
Generic Drug Cost
$2K

Patient Demographics

Average Patient Age
72.7 years
Avg HCC Risk Score
2.17
Gender Split
48% female / 52% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What ANNA PEYTON NAVARRETE, PHARMD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Jardiance
Empagliflozin
25
Atorvastatin Calcium
19
Ozempic
Semaglutide
17
Metformin Hcl Er
Metformin Hcl
15
Amlodipine Besylate
14
Rosuvastatin Calcium
13
Nano 2nd Gen Pen Needle
"Pen Needle
N/A
Toujeo Solostar
"Insulin Glargine
N/A

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Overview

How ANNA PEYTON NAVARRETE, PHARMD fits within the Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist landscape nationally.

12,377
Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Providers in US
55
States with Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist
256
Avg Claims per Provider

ANNA PEYTON NAVARRETE, PHARMD's 245 claims are below the specialty average of 256.

Nearby Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as PEYTON NAVARRETE.

Compare Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist nationally: see state-by-state distribution →

Frequently Asked Questions

What is ANNA PEYTON NAVARRETE, PHARMD's specialty?
ANNA PEYTON NAVARRETE, PHARMD specializes in Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist and practices in PALM SPRINGS, California. Credentials: PHARMD.
How much does ANNA PEYTON NAVARRETE, PHARMD prescribe under Medicare Part D?
In 2023, ANNA PEYTON NAVARRETE, PHARMD wrote 245 Medicare Part D claims totaling $78K in drug costs for 106 beneficiaries.
Where is ANNA PEYTON NAVARRETE, PHARMD located?
ANNA PEYTON NAVARRETE, PHARMD is located at 275 N EL CIELO RD, PALM SPRINGS, CA, 92262. Phone: (760) 320-8814.
What is ANNA PEYTON NAVARRETE, PHARMD's NPI number?
ANNA PEYTON NAVARRETE, PHARMD's National Provider Identifier (NPI) is 1033897814, issued on 07/10/2023.
Does ANNA PEYTON NAVARRETE, PHARMD prescribe more brand-name or generic drugs?
ANNA PEYTON NAVARRETE, PHARMD's prescribing is 41% brand-name and 59% generic drugs by claim count, with $75K in brand drug costs.
How many Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist providers are there in the US?
There are 12,377 Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist providers across 55 states in the US. The average Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist provider writes 256 Medicare Part D claims per year.
What drugs does ANNA PEYTON NAVARRETE, PHARMD prescribe most often?
Based on 2023 Medicare Part D data, ANNA PEYTON NAVARRETE, PHARMD's most frequently prescribed drugs include Jardiance, Atorvastatin Calcium, Ozempic. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ANNA PEYTON NAVARRETE, PHARMD accept Medicare?
ANNA PEYTON NAVARRETE, PHARMD appears in CMS Medicare data with 245 Part D claims and 106 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ANNA PEYTON NAVARRETE, PHARMD's credentials?
ANNA PEYTON NAVARRETE, PHARMD's NPI is 1033897814 with credentials PHARMD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology